We not only investigated the clinical significance of ADAMTS9-AS1 as a prognostic marker in glioma patients but also assessed the effects of ADAMTS9-AS1 on glioma cell proliferation, migration, and invasion based on a group of in vitro assays. The gene discussed is ADAMTS9; the disease is glioma.